<DOC>
	<DOC>NCT00544180</DOC>
	<brief_summary>To determine the satisfaction of subject with Actonel 35 mg Once a Week in the treatment of post-menopausal osteoporosis. Open, non-controlled, multi-center study.</brief_summary>
	<brief_title>ROSPA - Record on Satisfaction of Patients With Actonel 35 mg Once a Week</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Risedronate Sodium</mesh_term>
	<criteria>Inclusion criteria : Postmenopausal ambulatory women Established osteoporosis Exclusion criteria: History of cancer: basal cell or squamous cell carcinomadocumented 6month remission, Diagnosis of hypocalcemia, hyperparathyroidism, hyperthyroidism The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.</criteria>
	<gender>Female</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2009</verification_date>
</DOC>